8-METHOXY-3,4-DIHYDROISOQUINOLIN-1(2H)-ONE, 95%, 1g

L-Fmoc-aspartic acid alpha-t-butyl ester, 97.0%, 1g

2-(1H-2-Benzoimidazolyl)-ethylamine, 95.0%, 10g

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-pyrrole-1-carboxylate, 98%, 25g

3-Methoxy-3-methyl-1-butanol, min. 99%, for synthesis, 100 ml, glass packaging

1-bromoisoquinolin-4-amine, 95.0%, 250mg

6-Bromo-1-naphthoic acid, 95.0%, 1g

1-Methyl-6-nitro-1H-indazole, 95.0%, 25g

1-(4-Bromophenyl)ethane-1,2-diol, 95.0%, 250mg

2-Azaspiro[3.3]heptan-6-ol hydrochloride, 95.0%, 500mg

Methyl 2-methoxy-4-methylbenzoate, 95.0%, 5g

(1R,2R)-2-Fluorocyclopropan-1-amine hydrochloride, 98+%, 250mg

1-Isopropyl-[1,4]diazepane, 97.0%, 1g